
Processa Pharmaceuticals’ (PCSA) CEO David Young on Q4 2021 Results – Earnings Call Transcript
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q4 2021 Earnings Conference Call March 30, 2022 4:30 PM ET Company Participants Jim Stanker – Chief Financial Officer David Young – Chief Executive Officer Conference Call Participants Frank Brisebois – […]